FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to oncology. In order to predict efficiency of pre-operation radiotherapy of squamous carcinpmas of head and neck immune-enzyme analysis of TIMP-1 and TIMP-2 in blood serum is carried out. Level of MMP-2 and dimensions of primary tumour are additionally determined in accordance with international classification TNM. Discriminant functions Y1 and Y2, and efficiency of pre-operation radiotherapy is predicted on the basis of their comparison.
EFFECT: method increases accuracy and self-descriptiveness of prediction of efficiency of pre-operation radiotherapy of squamous carcinomas of head and neck due to assessment of the most informative parameters.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF CHEMORADIATION THERAPY OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2012 |
|
RU2505818C2 |
| METHOD FOR PREDICTION OF DEVELOPING LYMPHOGENIC METASTASES IN SQUAMOUS CELL CARCINOMA OF HEAD AND NECK FOLLOWING COMBINATION THERAPY | 2013 |
|
RU2527338C1 |
| METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK | 2009 |
|
RU2408284C2 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS | 2009 |
|
RU2426991C2 |
| METHOD FOR PREDICTING THE OUTCOME OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND OROPHARYNX | 2019 |
|
RU2708786C1 |
| METHOD FOR DISTANT METASTASES DEVELOPMENT RISK DEGREE DETERMINATION FOR PATIENTS WITH COLON CANCER | 2016 |
|
RU2623119C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF PROGRESSION IN A LONG PERIOD IN PATIENTS WITH SQUARE CELL CANCER OF THE HEAD AND NECK | 2021 |
|
RU2765013C1 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN BREAST CANCER PATIENTS AFTER ANTICANCER TREATMENT | 2010 |
|
RU2436099C1 |
| METHOD FOR PREDICTION OF RELAPSE DEVELOPMENT IN PATIENTS WITH ORAL MUCOSA CANCER | 2016 |
|
RU2635535C1 |
| METHOD FOR PREDICTION OF DEVELOPING HAEMATOGENOUS METASTASES FOLLOWING COMBINED TREATMENT OF KIDNEY CANCER | 2013 |
|
RU2528100C1 |
